Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exalgo in Chronic Low Back Pain
NCT00549042Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hydromorphone in chronic low back pain (CLBP), sponsored by Mallinckrodt Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
hydromorphone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00549042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549042.